TELK Insider Trading Activity and SEC Form 4 Filings
TELK insider trading summary
No open-market insider purchases or sales of Mabvax Therapeutics Holdings, Inc. (TELK) have been reported on SEC Form 4 in the past 12 months.
Latest TELK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 12, 2014 | Jim J. Antonopoulos | Insider | Sell | $71K (11,892 @ $6.00) |
| Dec 17, 2012 | Richard Barry | 10% Owner | Sell | $90K (48,390 @ $1.86) |
| Dec 13, 2012 | Richard Barry | 10% Owner | Sell | $95K (40,920 @ $2.31) |
| Dec 12, 2012 | Richard Barry | 10% Owner | Sell | $116K (61,798 @ $1.87) |
| Aug 23, 2010 | Edward W Cantrall | Director | Buy | $4K (6,000 @ $0.72) |
| Jun 24, 2010 | Richard J. Barry | 10% Owner | Buy | $7K (8,912 @ $0.75) |
| Jun 23, 2010 | Richard J. Barry | 10% Owner | Buy | $8K (10,449 @ $0.75) |
| Jun 22, 2010 | Richard J. Barry | 10% Owner | Buy | $20K (27,083 @ $0.75) |
| Jun 21, 2010 | Richard J. Barry | 10% Owner | Buy | $68K (90,217 @ $0.75) |
| Jun 18, 2010 | Richard J. Barry | 10% Owner | Buy | $41K (53,300 @ $0.76) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.